glp-1 analogue semaglutide Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has well-established weight-loss benefits. Cagrilintide, a long-acting of the satiety hormone amylin, has shown promise for weight loss in early trials. The potential benefit Strictures of GLP-1 analogues: Native

Hydration is Key Dehydration can worsen the headaches and dizziness sometimes associated with semaglutide

Lancet Diabetes Endocrinol (2023) 11(9):64456

The key strategies for minimizing regain during a short break include maintaining a high protein intake of 1.6-2.2 grams per kilogram of body weight daily, continuing or increasing resistance training to preserve muscle mass, planning meals in advance so hunger does not drive impulsive food choices, monitoring weight weekly but not daily to avoid overreacting to normal fluctuations, and staying hydrated since the body may retain more water without GLP-1 mediated effects on fluid balance

8 By allowing patients and clients to spread expenses over time, financing can make it easier to move forward with recommended care

Semaglutide was FDA-approved to treat obesity in 2021